Skip to main content
. 2022 Mar 28;111(6):1239–1247. doi: 10.1002/cpt.2574

Figure 1.

Figure 1

VENICE study design: vericiguat and nitroglycerin administration in patients with CCSs (chronic coronary syndromes).